Akshitarpana and Pana of Jivantyadi Ghrita in the management of Timira w.s.r. to presbyopia

Effect of Akshitarpana and pana of jivantyadi ghrita in the management of timira w.s.r. to presbyopia - An open labelled, randomized, comparative clinical trial

Status

Recruiting

Phases

Phase 1

Study type

Observational

Source

CTRI

Registry ID

CTRI/2017/09/009633

Enrollment

Registered

2017-09-05

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- The patients having the signs and symptoms of Timira (Presbyopia)

Interventions

Intervention1: Jivantyadi Ghrita: 10 ml twice a day with milk Tarpana Dose 30 ml per day 3 sittings for 7 days with 8 days interval Control Intervention1: Group A Jivantyadi Ghrita: 10 ml twice a day

Eligibility

Inclusion criteria

Inclusion criteria: 1.The patient of having age 35 to 55 years Irrespective of sex, caste, religion, occupation, state, etc 2.The patients having the signs and symptoms of Timira (Presbyopia) 3.The patient visual activity must be More than N/60

Exclusion criteria

Exclusion criteria: Patients having any other known ocular pathology. e.g. Cataract, Corneal opacity, H/o Iridocyclitis, chorio retinitis, Glaucoma.

Design outcomes

Primary

Measure	Time frame
Shaman of timira wsr to presbyopiaTimepoint: Shaman of timira wsr to presbyopia	—

Secondary

Measure	Time frame
efficacy of ayurvedic drugsTimepoint: nov2017	—

Countries

India

Contacts

Public ContactK S Patel

IPGT RA Jamnagar Gujarat

drkspatel2007@yahoo.co.in9427574566

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026